A collaboration between Sweati and Imperial College London has demonstrated a device that is capable of continuous monitoring of glucose, lactate and hydration.
Although the market for blood glucose monitoring (BGM) is expected to top $11.4 billion by 2023, Sweati is entering a highly competitive space: there are now many non-invasive BGM wearables, both in production and under development. Sweati, however, claims to be the only device that can monitor three biomarkers simultaneously and continuously by measuring ion concentrations in sweat. It will be made of fabric for comfort, as slim as two credit card, and small enough to fit in the palm of your hand.
The device is not yet available. According to the company, it is being trialled with a number of high-profile sports teams, as well as with elements of the UK and US military.
James Mayo, Founder and CEO commented: "Imagine a device that will be able to tell you when to fuel, when to hydrate and what pace to run at. That means no more hitting the dreaded “wall” whilst running a marathon. Sweati will make working out enjoyable and efficient."Martyn Boutelle, Professor of Biomedical Sensors Engineering in Imperial's Department of Bioengineering, said: "This work harnesses the latest in microfluidics and chip technology to monitor sweat in real time, providing a window into what's happening in the blood and tissue of the patch wearer without the need for invasive sampling. The information provided will enable performance to be optimised and wellbeing to be safeguarded."